Belgium· BE-AMP-SAM151733-00
Paronal 10000 IU
A asparaginase product containing asparaginase, registered in Belgium by Takeda Belgium. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Asparaginase is registered in 15 of 19 countries.
Countries holding a registration under ATC L01XX02 (asparaginase), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Asparaginase · ATC L01XX02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Asparaginase
- Manufacturer
- Takeda Belgium
- Country
- Belgium (BE)
- ATC code
- L01XX02
- ATC class
- Asparaginase
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0274720
- be_apb0737114
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
280 interactions on record for asparaginase.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Asparaginase · interactions on record
280 records
- 7 severe
- 273 moderate
Most severe, free to view
- ClotrimazoleA01AB18moderate
- Chenodeoxycholic acidA05AA01moderate
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Asparaginase in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSPECTRILAMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- FinlandSpectrilaMedac Gesellschaft Für Klinische Spezialpräparate mbH
- United KingdomAsparaginase 10,000unit powder for solution for injection vialsSpecial Order
- JapanL-アスパラギナーゼ協和キリン
- SwedenEnrylaze 10 mg/0,5 ml Injektions-/infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
- NorwayEnrylazeJazz Pharmaceuticals Ireland Limited
- PolandSpectrilamedac Gesellschaft fuer klinische Spezialpraeparate mbH
- United StatesRylazeJazz Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enrylaze, Spectrila
- Liechtenstein · Enrylaze, Spectrila
- Norway · Enrylaze, Spectrila
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9ddc1640-5ccd-4b6f-839d-13c07320de44 GET /v1/drugs/9ddc1640-5ccd-4b6f-839d-13c07320de44?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Paronal 10000 IU",
"name_fr": "Paronal 10000 IU",
"name_nl": "Paronal 10000 IU",
"amp_code": "SAM151733-00",
"strengths": [
"10000.0000"
],
"pack_count": 2,
"substances": [
"Asparaginase"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Asparaginase",
"authorisation_numbers": [
"BE151733"
]
}See everything about asparaginase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.